EVAR术后II型内漏致瘤囊扩大的术前危险因素分析
该回顾性队列研究纳入320例因真性腹主动脉瘤行EVAR且随访≥12个月的患者,中位随访60.8个月,42%出现II型内漏,其中35%发生瘤囊扩大。多因素分析显示CKD≥4期、通畅的肠系膜下动脉及通畅腰动脉数量是瘤囊扩大的独立危险因素。
要点
- CKD≥4期、通畅IMA及通畅腰动脉数量是EVAR术后II型内漏致瘤囊扩大的独立危险因素。
- 通畅IMA的HR最高(17.85),对长期瘤囊扩大影响似最大。
- 术前处理通畅IMA可能有助于降低瘤囊扩大发生率。
核心结论
- CKD≥4期、通畅IMA及通畅腰动脉数量是EVAR术后II型内漏致瘤囊扩大的独立危险因素。
- 通畅IMA的HR最高,似对长期瘤囊扩大影响最大。
研究设计与样本
- 回顾性队列研究,2006年1月至2018年12月单中心519例真性腹主动脉瘤EVAR。
- 纳入使用市售分叉支架、随访无I/III型内漏且随访≥12个月的320例患者。
主要发现
- 中位随访60.8个月,320例中135例(42%)出现II型内漏。
- 135例II型内漏中47例(35%)发生瘤囊扩大。
- 多因素分析:CKD≥4期HR 4.65(95%CI 2.13-10.15,P=0.001)。
- 通畅IMA HR 17.85(95%CI 2.46-129.73,P<0.001)。
- 通畅腰动脉数量HR 1.37(95%CI 1.13-1.68,P=0.002)。
临床怎么用
- 术前评估CKD分期、IMA通畅性及腰动脉数量,识别II型内漏致瘤囊扩大高危患者。
- 对通畅IMA患者可考虑术前干预以降低瘤囊扩大风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although the preoperative risk factors associated with the occurrence of type II endoleak (ETII) after endovascular aortic repair (EVAR) have gradually become more evident, the preoperative risk factors associated with aneurysm sac enlargement caused by ETII remain unclear. This study aimed to determine the preoperative risk factors associated with aneurysm sac enlargement caused by ETII after EVAR. METHODS: This retrospective cohort study reviewed 519 EVARs performed for true abdominal aortic aneurysm between January 2006 and December 2018 at our institution. EVARs using commercially available bifurcated devices with no type I or III endoleaks during follow-up and with ≥12 months follow-up were included. A total of 320 patients were enrolled in the study. To identify the preoperative risk factors of sac enlargement after EVAR, Cox regression analysis was used to assess preoperative data. RESULTS: The median follow-up period was 60.8 months. Overall, 135 of 320 patients (42%) had ETII during follow-up, and 47 of 135 patients (35%) developed aneurysm sac enlargement. Multivariate analysis revealed that chronic kidney disease (CKD) stage ≥4 (hazard ratio [HR], 4.65; 95% confidence interval [CI], 2.13-10.15; P = 0.001), patent inferior mesenteric artery (IMA) (HR, 17.85; 95% CI, 2.46-129.73; P< 0.001), and number of patent lumbar arteries (LAs) (HR, 1.37; 95% CI, 1.13-1.68; P= 0.002) were risk factors of aneurysm sac enlargement caused by ETII. CONCLUSIONS: CKD stage ≥4, patent IMA, and number of patent LAs were independent risk factors for aneurysm sac enlargement after EVAR. In particular, patent IMA had the highest HR and seemed to have the greatest impact on long-term aneurysm sac enlargement. Hence, taking preoperative measures to address a patent IMA appears to be important in reducing the incidence of sac enlargement.
引用
- Ide T, Masada K, Kuratani T, et al. Risk Analysis of Aneurysm Sac Enlargement Caused by Type II Endoleak after Endovascular Aortic Repair. Ann Vasc Surg. 2021. PMID: 34461238. doi:10.1016/j.avsg.2021.06.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。